Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.2025
Delayed Data
As of Aug 28
 -0.0015 / -0.74%
Today’s Change
0.17
Today|||52-Week Range
0.39
-10.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-15.1M1.5M-96.6M28.9M
 
 
 
 
 
Depreciation484.2K423.3K453.7K581.9K
 
 
 
 
 
Total Other Cash Flow13.8M-2.7M91.9M-44.5M
 
 
 
 
 
Funds From Operations-765.9K-793.9K-4.2M-14.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-371.8K1.1M-32.0K163.1K
 
 
 
 
 
Net Cash Flow - Operating Activities-394.1K-1.9M-4.2M-15.1M
 
 
 
 
 
 
InvestingDecrease In Investments--0.000.005.0M
 
 
Capital Expenditures-623.3K-153.0K-502.3K-2.0M
 
 
 
 
 
Other Investing - Uses0.00-1.000.000.00
 
 
Other Investing - Sources10.8K12.8K2.8K-123.9K
 
 
 
 
 
Net Cash Flow Investing-657.8K-191.8K-557.7K2.9M
 
 
 
 
 
 
FinancingShort Term Borrowings-13.4K593.7K527.2K-164.7K
 
 
 
 
 
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction--0.000.00-1.1M
 
 
Net Proceeds Stock Sale-92.2K1.0M10.9M14.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00240.1K1.000.00
 
 
 
Other Uses - Financing0.000.0048.0K0.00
 
 
Net Cash Flow - Financing-105.6K1.8M11.3M12.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash-1.2M-299.4K6.6M522.4K